M

Mursla

15 employees

Nextgen multi-omics liquid biopsy and precision medicine tests via tissue-specific extracellular vesicles

Basic info

Industry

biotechnology research

Sectors

computational biology
Medical Device
Biotechnology
techbio
biology
proteomics
liver
Internet of Things
biomarker
oncology
Health Diagnostics
diagnostics
transcriptomics
cancer
extracellular vesicle
liquid biopsy
Information Technology
biotech

Date founded

2019

Funding rounds raised

M

Mursla raised undisclosed on March 30, 2022

Investors: Greater London Authority

FAQ